Table 4 Number, sales volume (in million SUs) and proportion (%) of the systemic antibiotic FDC formulations banned as a result of the first initiative
Formulations | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Banned in 2019 | No | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 8 |
1.4% | 1.3% | 1.4% | 1.5% | 1.6% | 1.7% | 1.7% | 1.9% | 1.7% | 1.8% | 1.9% | 2.1% | 2.0% | ||
Vol | 11.2 | 14.4 | 19.3 | 24.6 | 31.0 | 37.8 | 45.3 | 49.3 | 46.1 | 47.6 | 47.6 | 11.2 | 3.7 | |
0.3% | 0.4% | 0.5% | 0.6% | 0.6% | 0.7% | 0.8% | 0.8% | 0.8% | 0.9% | 1.0% | 0.2% | 0.1% | ||